What must a pharmacy communicate to a prescriber if an interchangeable biologic product is dispensed?

When a pharmacy dispenses an interchangeable biologic product, it is essential to communicate the name and manufacturer of the biologic product to the prescriber. This is important for several reasons.

Firstly, interchangeable biologics are products that have been shown to be safe and effective substitutes for the original biologic product. By informing the prescriber of the specific interchangeable product that was dispensed, they can maintain an accurate record of the patient's medication history and make informed decisions regarding ongoing therapy.

Secondly, knowing the manufacturer is crucial because different manufacturers may have slight variances in their formulation or handling, which could affect efficacy or patient response. This information helps ensure that the prescriber is aware of exactly what has been provided to the patient, fostering continuity of care.

While the other aspects mentioned in the other choices might be relevant in different contexts, they are not required communication when an interchangeable biologic is dispensed. For example, the cost may vary and is typically not necessary information for the prescriber to know. Likewise, the quantity dispensed is often not a critical detail unless specific dosing instructions are affected, and patient health history is a broader topic that is not directly tied to the specifics of the biologic product itself. Thus, conveying the name and manufacturer